| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Future Medicinal Chemistry (Q2) | ||
| Dergi ISSN | 1756-8919 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 12-2025 |
| Cilt / Sayı / Sayfa | 17 / 24 / 2975–2986 | DOI | 10.1080/17568919.2025.2592533 |
| Makale Linki | https://doi.org/10.1080/17568919.2025.2592533 | ||
| UAK Araştırma Alanları |
Organik Kimya
|
||
| Özet |
| AimTo design, synthesize, and evaluate a series of thiosemicarbazone and thiazolidin-4-one hybrids bearing arylsulfonate groups as potential androgen receptor-targeted anticancer agents.Materials and methodsThe compounds were synthesized via sequential sulfonylation, thiosemicarbazone formation, and cyclization to thiazolidin-4-ones. The structures of the compounds were characterized using NMR (1H and 13C), FTIR, and HRMS spectroscopic techniques. In vitro cytotoxicity was assessed against prostate cancer (PC3) and human umbilical vein endothelial cell lines (HUVEC) using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Molecular docking and MM-GBSA calculations were performed to predict binding affinities toward the androgen receptor. Molecular dynamics simulations (250 ns) were conducted to evaluate the stability and dynamics of the ligand – protein … |
| Anahtar Kelimeler |
| androgen receptor | PC3 | prostate cancer | thiazolidine-4-one | Thiosemicarbazone |
| Atıf Sayıları | |
| Web of Science | 15 |
| Scopus | 3 |
| Google Scholar | 3 |
| Dergi Adı | Future Medicinal Chemistry |
| Yayıncı | Taylor and Francis Ltd. |
| Açık Erişim | Hayır |
| ISSN | 1756-8919 |
| E-ISSN | 1756-8927 |
| CiteScore | 4,8 |
| SJR | 0,501 |
| SNIP | 0,575 |